Researchers study babies’ stools to determine how celiac disease develops
08/21/2017Some say biopsy still needed, others say blood tests alone are sufficient if antibody levels are high enough
08/09/2017But you may be less likely if you follow the gluten-free diet for other reasons
07/19/2017New study challenges claims these over-the-counter products break down gluten
07/07/2017A large-scale study concludes the biopsy is unnecessary more than half the time
06/21/2017Babies who get more gastrointestinal infections more likely to develop celiac disease
06/01/2017A review of current evidence
05/24/2017Three tools make it easier to follow clinical trials and participate
05/10/2017Patients worry about whether their medications are safe on the gluten-free diet
05/05/2017Lack of whole grains may actually increase risk of heart disease
03/30/2017Patients in CeliAction study improve whether given drug or not
09/06/2016Drug to treat non-responsive and refractory celiac disease being tested
09/01/2016Beyond Celiac developing technology to bring stakeholders together
08/08/2016New research shows promise in turning off the immune response to gluten in those with celiac disease
07/06/2016Researchers are working on an experimental new drug for celiac disease.
05/23/2016A research study is testing an investigational medication called AMG 714 for people with refractory celiac disease type II.
05/12/2016A new clinical trial for celiac disease is underway.
03/31/2016Multinational study to evaluate the potential of Anti-IL-15 antibody, AMG 714, to treat rare in situ small bowel T cell ymphoma.
03/17/2016Glutenase for in-vivo gluten degradation is a leading candidate for celiac disease
03/03/2016Promising compound to begin phase 3 clinical trials for treatment of celiac disease.
09/03/2015Research to inform therapeutic and diagnostic development for patients of all ages
06/22/2015Cour Pharmaceuticals discusses recent study data the the 16th International Celiac Disease Symposium (ICDS).
05/20/2015Sanofi and Selecta Biosciences, Inc. collaborate on new immunotherapy for celiac disease.
03/02/2015Company to develop AMG 714 for the treatment of diet non-responsive celiac disease and refractory celiac disease (celiac disease-triggered T-cell lymphoma).
02/23/2015Emerging therapeutic company to initially focus on addressing the significant medical and socioeconomic needs of patients with celiac disease
Newer Posts 1 2 3 4 5 Older Posts
Opt-in to stay up-to-date on the latest news.
Yes, I want to advance research No, I'd prefer not to
